AA
INSY
AlphaMark Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-740
| Closed | – | – | 635 |
|
|
2019
Q4 | $0 | Sell |
740
-25
| -3% | – | ﹤0.01% | 529 |
|
|
2019
Q3 | $0 | Hold |
765
| – | – | ﹤0.01% | 532 |
|
|
2019
Q2 | $0 | Hold |
765
| – | – | ﹤0.01% | 541 |
|
|
2019
Q1 | $4K | Hold |
765
| – | – | ﹤0.01% | 432 |
|
|
2018
Q4 | $3K | Hold |
765
| – | – | ﹤0.01% | 428 |
|
|
2018
Q3 | $8K | Hold |
765
| – | – | ﹤0.01% | 377 |
|
|
2018
Q2 | $6K | Buy |
765
+25
| +3% | +$196 | ﹤0.01% | 430 |
|
|
2018
Q1 | $4K | Hold |
740
| – | – | ﹤0.01% | 444 |
|
|
2017
Q4 | $7K | Hold |
740
| – | – | ﹤0.01% | 390 |
|
|
2017
Q3 | $7K | Hold |
740
| – | – | ﹤0.01% | 379 |
|
|
2017
Q2 | $9K | Hold |
740
| – | – | ﹤0.01% | 362 |
|
|
2017
Q1 | $8K | Hold |
740
| – | – | ﹤0.01% | 359 |
|
|
2016
Q4 | $7K | Hold |
740
| – | – | ﹤0.01% | 354 |
|
|
2016
Q3 | $9K | Buy |
+740
| New | +$9K | ﹤0.01% | 254 |
|